Validea Detailed Fundamental Analysis

Elevance Health Inc (ELV) scored 75% on Validea's Multi-Factor Investor model, which is based on Pim van Vliet's strategy for low volatility stocks with strong momentum and high net payout yields. Despite passing market cap and standard deviation tests, ELV showed neutral performance in momentum and net payout yield, resulting in a "FAIL" on the final rank for this strategy. This score falls below the 80% threshold typically indicating "some interest," suggesting ELV does not currently align with this quantitative low-risk, high-return investment approach.

Analysis

Elevance Health (ELV) was assessed using Validea's Multi-Factor Investor model, a quantitative strategy derived from Pim van Vliet's research that prioritizes low-volatility stocks with strong momentum and high net payout yields. The company received a score of 75%, falling short of the 80% threshold that indicates strategist interest. While ELV, a large-cap health insurance stock, passed the model's criteria for market capitalization and standard deviation, confirming its low-risk characteristics, it displayed insufficient strength in other key areas. The stock was rated "NEUTRAL" on both its "Twelve Minus One Momentum" and "Net Payout Yield." Consequently, these neutral readings led to an overall "FAIL" on the strategy's final rank, indicating that despite its favorable low-volatility profile, ELV does not currently meet the comprehensive criteria for this specific low-risk, high-return investment framework.

Key Decisions for Investors

• Investors who follow quantitative, low-risk factor strategies should note that ELV currently fails this specific screen due to its neutral momentum and net payout yield, making it an unattractive candidate based on this model's rules.
• While ELV exhibits a desirable low-volatility profile, its mediocre momentum and net payout yield metrics warrant further scrutiny for fundamental investors, suggesting a potential need to investigate the underlying drivers of these weaker factors.
• Portfolio managers should monitor for any significant improvement in ELV's momentum or changes in its capital return policy, as these are the primary factors holding back its score in this quantitative screen and a positive shift could alter its attractiveness.